Cargando…
Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients
Although immunotherapy is already a staple of cancer care, many patients may not benefit from these cutting-edge treatments. A crucial field of research now focuses on figuring out how to improve treatment efficacy and assess the resistance mechanisms underlying this uneven response. For a good resp...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215686/ https://www.ncbi.nlm.nih.gov/pubmed/37238995 http://dx.doi.org/10.3390/biomedicines11051325 |